Bambusa Therapeutics

HONG KONG, June 15, 2026 Akeso, Inc. has announced the enrollment of the first patient in the Phase Ib/II...

BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...

BOSTON, MASSACHUSETTS, April 30, 2026 Bambusa Therapeutics has announced the successful completion of patient enrollment in its Phase 1b/2a...